By Brinter Ltd.
Brinter® joins influential Termis-Americas life sciences conference
Santa Monica, CA and Winston-Salem, NC, and Turku, Finland: – Pioneering clinical bio-implant and 3D bioprinting platform developer and manufacturer Brinter® will emphasize its growing presence among the rapidly growing American tissue engineering and regenerative medicine community when it appears as a sponsor and exhibitor at the TERMIS Americas conference in Boston.
The Brinter® display stand at Booth 26 in the Exhibition Zone at the Boston Marriott Copley Place will showcase the company’s highly innovative and modular Brinter® ONE 3D bioprinter, with live demonstrations of 3D printing of meniscus bio-implants, and other constructs to demonstrate the medical and research capabilities of the Brinter® platform.
Introduction to 3D bioprinting
The stand team, led by Brinter® CEO and co-founder Tom Alapaattikoski, supported by Applications and Innovation Manager Dr. Eva Mueller and Science and Operations Manager Dr. Matthew Brovold, will conduct informative student sessions to give young scientists ‘hands on’ introductions to the technology.
The scientific team will be at the booth throughout the conference to answer any visitor questions about applications of the technology and Brinter’s own in-house meniscus bio-implant R&D, and particularly its recent advances in regenerative cartilage applications and innovative biomaterials. The team is constantly looking for new biomaterial in-licensing opportunities to expand the material portfolio and accelerate our in-house R&D applications.
New American connections
Tom Alapaattikoski commented: “We are very excited about attending this event for the first time with opportunities to meet the wider TERMIS community.”
“We believe this conference will provide us with excellent opportunities to forge new relationships along with academic and industry partnerships; promoting and showcasing our Brinter® ONE technology and our promising tissue engineering and regenerative medicine applications such as our flagship meniscus bio-implant,” he added.
Brinter® will support its sponsorship of the event by offering 20% discounts on bioprinter purchases to academic researchers up to May 31, 2023.
Founded in 2020 via partial demerger in Turku, Finland, Brinter® is the meniscus bio-implant developer and manufacturer of a modular multi-material 3D bioprinting platform scalable from manual R&D to automated production. The company works with science and bioengineering organizations to integrate 3D bioprinting into their research, manufacturing, and treatment methods. The goal is to break through current technological limitations and improve people’s quality of life.
Brinter® has bootstrapped its growth since 2018, when it launched its first commercial product in 2020, and is currently active in more than ten countries, including the USA, Germany, the UK, and India.
Customers of the company now include bio and pharmaceutical companies like Nanoform, as well as research organizations like UCLA, Michigan State University, Wake Forest Institute for Regenerative Medicine, VTT, BEST group at the University of Glasgow, Johannes Gutenberg University of Mainz, the University of Oulu, and the University of Helsinki, whose directors are enthusiastic about the technology’s potential.
For more information, visit www.brinter.com.
About TERMIS® Americas Conference 2023
Founded in 2005 from the of the Tissue Engineering Society International (TESi) and Regenerative Medicine Society (RMS), the Tissue Engineering and Regenerative Medicine International Society (TERMIS®) is an international learned society dedicated to these new fields of medicine.
The society incorporates continental Chapters (TERMIS-Americas, TERMIS-AP for Asia Pacific and TERMIS-EU for Europe), with each holding conferences in succeeding years, with a World Congress every third year.
The TERMIS-Americas Conference & Exhibition 2023 is a four-day event opening April 11 at the Boston Marriott Copley Place Hotel.
Themed ‘Tissue Engineering Strategies for Human Health and Longevity’, the conference will include Keynote Presentations from Dr. Marianne Ellis from University of Bath, UK, on ‘Cellular Agriculture and Food Tissue Engineering’ and Dr. Mayana Zata from Brazil’s University of São Paulo on ‘Regenerative Approaches for Tissue Disorders’. The conference will also see the presentation of the 2023 TERMIS Awards.
The event is organised by TERMIS Americas with further information at: https://am2023.termis.org
Click on Connect with Brinter at TERMIS-AMERICAS 2023 for further information.